migril tablets
inova pharmaceuticals (pty) ltd - ergotamine tartrate; cyclizine hydrochloride; caffeine hydrate - tablet - each tablet contains ergotamine ; tartrate ep 2.0mg, cyclizine hydrochloride; bp 50,0mg and caffeine bp equivalent to ; caf
dihydroergotamine mesylate injection
hikma farmaceutica - dihydroergotamine mesylate (unii: 81axn7r2qt) (dihydroergotamine - unii:436o5hm03c) -
ergalan
*** company unknown *** - caffeine 100mg; ergotamine tartrate 1mg; meclozine hydrochloride 10mg - tablet - active: caffeine 100mg ergotamine tartrate 1mg meclozine hydrochloride 10mg
ergodryl
pfizer new zealand limited - caffeine citrate 100mg; diphenhydramine hydrochloride 25mg; ergotamine tartrate 1mg - capsule - 100mg/25mg/1mg - active: caffeine citrate 100mg diphenhydramine hydrochloride 25mg ergotamine tartrate 1mg excipient: gelatin hydrogenated vegetable oil lactose monohydrate magnesium stearate purified talc
medihaler ergotamine
inova pharmaceuticals (new zealand) limited - ergotamine tartrate 0.36mg - aerosol inhaler, metered dose - 0.36 mg/dose - active: ergotamine tartrate 0.36mg
migril
glaxosmithkline nz limited - caffeine 100mg; cyclizine hydrochloride 50mg; ergotamine tartrate 2mg - tablet - active: caffeine 100mg cyclizine hydrochloride 50mg ergotamine tartrate 2mg excipient: gelatin
cafergot tablet
jaffar pharmacy - caffeine, ergotamine tartrate - tablet
dromelate- dihydroergotamine mesylate injection, solution
it3 medical llc - dihydroergotamine mesylate (unii: 81axn7r2qt) (dihydroergotamine - unii:436o5hm03c) - dihydroergotamine mesylate injection, usp is indicated for the acute treatment of migraine headaches with or without aura and the acute treatment of cluster headache episodes. there have been a few reports of serious adverse events associated with the coadministration of dihydroergotamine and potent cyp 3a4 inhibitors, such as protease inhibitors and macrolide antibiotics, resulting in vasospasm that led to cerebral ischemia and/or ischemia of the extremities. the use of potent cyp 3a4 inhibitors (ritonavir, nelfinavir, indinavir, erythromycin, clarithromycin, troleandomycin, ketoconazole, itraconazole) with dihydroergotamine is, therefore contraindicated (see warnings: cyp 3a4 inhibitors) dihydroergotamine mesylate injection, usp should not be given to patients with ischemic heart disease (angina pectoris, history of myocardial infarction, or documented silent ischemia) or to patients who have clinical symptoms or findings consistent with coronary artery vasospasm including prinzmetal's variant angina. (see
trudhesa- dihydroergotamine mesylate spray, metered
impel pharmaceuticals inc. - dihydroergotamine mesylate (unii: 81axn7r2qt) (dihydroergotamine - unii:436o5hm03c) - trudhesa is indicated for the acute treatment of migraine with or without aura in adults. limitations of use trudhesa is not indicated for the preventive treatment of migraine. trudhesa is not indicated for the management of hemiplegic or basilar migraine. trudhesa is contraindicated in patients: - with concomitant use of strong cyp3a4 inhibitors, such as protease inhibitors (e.g., ritonavir, nelfinavir, or indinavir), macrolide antibiotics (e.g., erythromycin or clarithromycin), and antifungals (ketoconazole or itraconazole) [see warnings and precautions (5.1) and drug interactions (7.1)] - with ischemic heart disease (angina pectoris, history of myocardial infarction, or documented silent ischemia) or patients who have clinical symptoms or findings consistent with coronary artery vasospasm, including prinzmetal's variant angina [see warnings and precautions (5.4)] - with uncontrolled hypertension [see warnings and precautions (5.5)] - with peripheral arterial disease - with sepsis - following vascular surge
avamigran tablets film-coated
bosnalijek d.d. - propyphenazone, caffeine, camylofin (camylofin hydrochloride), mecloxamine (mecloxamine citrate), ergotamine (ergotamine tartrate) - tablets film-coated - 200mg+ 80mg+ 25mg+ 20mg+ 0,75mg